ID   EPHB1_RAT               Reviewed;         984 AA.
AC   P09759;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 2.
DT   24-JUL-2024, entry version 221.
DE   RecName: Full=Ephrin type-B receptor 1;
DE            EC=2.7.10.1;
DE   AltName: Full=ELK;
DE   AltName: Full=Tyrosine-protein kinase receptor EPH-2;
DE   Flags: Precursor;
GN   Name=Ephb1; Synonyms=Elk, Epth2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AUTOPHOSPHORYLATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=2017163; DOI=10.1128/mcb.11.5.2496-2502.1991;
RA   Lhotak V., Greer P., Letwin K., Pawson T.;
RT   "Characterization of elk, a brain-specific receptor tyrosine kinase.";
RL   Mol. Cell. Biol. 11:2496-2502(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 605-984.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=2485255;
RA   Letwin K., Yee S.P., Pawson T.;
RT   "Novel protein-tyrosine kinase cDNAs related to fps/fes and eph cloned
RT   using anti-phosphotyrosine antibody.";
RL   Oncogene 3:621-627(1988).
CC   -!- FUNCTION: Receptor tyrosine kinase which binds promiscuously
CC       transmembrane ephrin-B family ligands residing on adjacent cells,
CC       leading to contact-dependent bidirectional signaling into neighboring
CC       cells. The signaling pathway downstream of the receptor is referred to
CC       as forward signaling while the signaling pathway downstream of the
CC       ephrin ligand is referred to as reverse signaling. Cognate/functional
CC       ephrin ligands for this receptor include EFNB1, EFNB2 and EFNB3. During
CC       nervous system development, regulates retinal axon guidance redirecting
CC       ipsilaterally ventrotemporal retinal ganglion cells axons at the optic
CC       chiasm midline. This probably requires repulsive interaction with
CC       EFNB2. In the adult nervous system together with EFNB3, regulates
CC       chemotaxis, proliferation and polarity of the hippocampus neural
CC       progenitors. In addition to its role in axon guidance also plays an
CC       important redundant role with other ephrin-B receptors in development
CC       and maturation of dendritic spines and synapse formation. May also
CC       regulate angiogenesis. More generally, may play a role in targeted cell
CC       migration and adhesion. Upon activation by EFNB1 and probably other
CC       ephrin-B ligands activates the MAPK/ERK and the JNK signaling cascades
CC       to regulate cell migration and adhesion respectively (By similarity).
CC       Involved in the maintenance of the pool of satellite cells (muscle stem
CC       cells) by promoting their self-renewal and reducing their activation
CC       and differentiation (By similarity). {ECO:0000250|UniProtKB:P54762,
CC       ECO:0000250|UniProtKB:Q8CBF3}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- SUBUNIT: Heterotetramer upon binding of the ligand. The heterotetramer
CC       is composed of an ephrin dimer and a receptor dimer. Oligomerization is
CC       probably required to induce biological responses. Interacts with EPHB6;
CC       transphosphorylates EPHB6 to form an active signaling complex.
CC       Interacts with PICK1. Interacts (through Tyr-594) with NCK1 (via SH2
CC       domain); activates the JUN cascade to regulate cell adhesion. The
CC       ligand-activated form interacts (through Tyr-928) with GRB7 and GRB10
CC       (via SH2 domains). The ligand-activated form interacts (residues within
CC       the catalytic domain) with GRB2 (via SH2 domain). Interacts with GRB2,
CC       SHC1 and SRC; activates the MAPK/ERK cascade to regulate cell
CC       migration. Interacts with CBL; regulates receptor degradation through
CC       ubiquitination. Interacts with ACP1 (By similarity).
CC       {ECO:0000250|UniProtKB:P54762, ECO:0000250|UniProtKB:Q8CBF3}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P54762};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:P54762}.
CC       Early endosome membrane {ECO:0000250|UniProtKB:P54762}. Cell
CC       projection, dendrite {ECO:0000250|UniProtKB:Q8CBF3}.
CC   -!- TISSUE SPECIFICITY: Restricted to brain and testes.
CC       {ECO:0000269|PubMed:2017163}.
CC   -!- PTM: Phosphorylated. Autophosphorylation is stimulated by the ligand
CC       EFNB1. Required for interaction with SH2 domain-containing interactors,
CC       for activation of the MAPK/ERK and JUN signaling cascades and for
CC       ubiquitination by CBL (By similarity). {ECO:0000250|UniProtKB:P54762}.
CC   -!- PTM: Ubiquitinated; (EFNB1)ligand-induced poly- and/or multi-
CC       ubiquitination by CBL is regulated by SRC and leads to lysosomal
CC       degradation. {ECO:0000250|UniProtKB:P54762,
CC       ECO:0000250|UniProtKB:Q8CBF3}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M59814; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; X13411; CAA31777.1; -; mRNA.
DR   PIR; A39753; A39753.
DR   RefSeq; NP_001097998.1; NM_001104528.1.
DR   RefSeq; XP_017450939.1; XM_017595450.1.
DR   AlphaFoldDB; P09759; -.
DR   SMR; P09759; -.
DR   BioGRID; 246515; 2.
DR   CORUM; P09759; -.
DR   DIP; DIP-138N; -.
DR   STRING; 10116.ENSRNOP00000010634; -.
DR   BindingDB; P09759; -.
DR   ChEMBL; CHEMBL4739675; -.
DR   GuidetoPHARMACOLOGY; 1830; -.
DR   GlyCosmos; P09759; 3 sites, No reported glycans.
DR   GlyGen; P09759; 3 sites.
DR   iPTMnet; P09759; -.
DR   PhosphoSitePlus; P09759; -.
DR   SwissPalm; P09759; -.
DR   PaxDb; 10116-ENSRNOP00000010634; -.
DR   Ensembl; ENSRNOT00000010634.6; ENSRNOP00000010634.7; ENSRNOG00000007865.7.
DR   Ensembl; ENSRNOT00055022822; ENSRNOP00055018506; ENSRNOG00055013309.
DR   Ensembl; ENSRNOT00060016593; ENSRNOP00060012956; ENSRNOG00060009826.
DR   Ensembl; ENSRNOT00065011708; ENSRNOP00065008554; ENSRNOG00065007485.
DR   GeneID; 24338; -.
DR   KEGG; rno:24338; -.
DR   UCSC; RGD:2556; rat.
DR   AGR; RGD:2556; -.
DR   CTD; 2047; -.
DR   RGD; 2556; Ephb1.
DR   eggNOG; KOG0196; Eukaryota.
DR   GeneTree; ENSGT00940000155297; -.
DR   HOGENOM; CLU_000288_141_4_1; -.
DR   InParanoid; P09759; -.
DR   OMA; EEVIGAX; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; P09759; -.
DR   TreeFam; TF315608; -.
DR   BRENDA; 2.7.10.1; 5301.
DR   Reactome; R-RNO-2682334; EPH-Ephrin signaling.
DR   Reactome; R-RNO-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-RNO-3928664; Ephrin signaling.
DR   Reactome; R-RNO-3928665; EPH-ephrin mediated repulsion of cells.
DR   PRO; PR:P09759; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000007865; Expressed in brain and 17 other cell types or tissues.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR   GO; GO:0031901; C:early endosome membrane; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0032433; C:filopodium tip; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008046; F:axon guidance receptor activity; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:RGD.
DR   GO; GO:0005005; F:transmembrane-ephrin receptor activity; ISS:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; ISS:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; ISS:UniProtKB.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; ISO:RGD.
DR   GO; GO:0060326; P:cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0031589; P:cell-substrate adhesion; ISS:UniProtKB.
DR   GO; GO:0021952; P:central nervous system projection neuron axonogenesis; ISS:UniProtKB.
DR   GO; GO:0021545; P:cranial nerve development; ISO:RGD.
DR   GO; GO:0060996; P:dendritic spine development; IGI:MGI.
DR   GO; GO:0060997; P:dendritic spine morphogenesis; ISS:UniProtKB.
DR   GO; GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; ISS:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030010; P:establishment of cell polarity; ISS:UniProtKB.
DR   GO; GO:0021934; P:hindbrain tangential cell migration; IMP:RGD.
DR   GO; GO:0001771; P:immunological synapse formation; IGI:MGI.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:1902725; P:negative regulation of satellite cell differentiation; ISS:UniProtKB.
DR   GO; GO:1902723; P:negative regulation of skeletal muscle satellite cell proliferation; ISS:UniProtKB.
DR   GO; GO:0061351; P:neural precursor cell proliferation; ISS:UniProtKB.
DR   GO; GO:0022008; P:neurogenesis; ISS:UniProtKB.
DR   GO; GO:0021631; P:optic nerve morphogenesis; ISO:RGD.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; ISS:UniProtKB.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0046328; P:regulation of JNK cascade; ISS:UniProtKB.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; ISS:UniProtKB.
DR   GO; GO:0014719; P:skeletal muscle satellite cell activation; ISS:UniProtKB.
DR   CDD; cd10476; EphR_LBD_B1; 1.
DR   CDD; cd00063; FN3; 2.
DR   CDD; cd05065; PTKc_EphR_B; 1.
DR   CDD; cd09551; SAM_EPH-B1; 1.
DR   Gene3D; 2.60.40.1770; ephrin a2 ectodomain; 1.
DR   Gene3D; 2.60.120.260; Galactose-binding domain-like; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   Gene3D; 2.10.50.10; Tumor Necrosis Factor Receptor, subunit A, domain 2; 1.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR034231; EphB1_rcpt_lig-bd.
DR   InterPro; IPR042819; EphB1_SAM.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR050449; Ephrin_rcpt_TKs.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   PANTHER; PTHR46877; EPH RECEPTOR A5; 1.
DR   PANTHER; PTHR46877:SF17; EPHRIN TYPE-B RECEPTOR 1; 1.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00014; FNTYPEIII.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM01411; Ephrin_rec_like; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; Fibronectin type III; 1.
DR   SUPFAM; SSF49785; Galactose-binding domain-like; 1.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell adhesion; Cell membrane; Cell projection; Endosome;
KW   Glycoprotein; Kinase; Membrane; Neurogenesis; Nucleotide-binding;
KW   Phosphoprotein; Receptor; Reference proteome; Repeat; Signal; Transferase;
KW   Transmembrane; Transmembrane helix; Tyrosine-protein kinase;
KW   Ubl conjugation.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   CHAIN           18..984
FT                   /note="Ephrin type-B receptor 1"
FT                   /id="PRO_0000016825"
FT   TOPO_DOM        18..540
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        541..563
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        564..984
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          19..201
FT                   /note="Eph LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00883"
FT   DOMAIN          322..432
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          433..528
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          619..882
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          911..975
FT                   /note="SAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   MOTIF           982..984
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        744
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         625..633
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         651
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         600
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P54753"
FT   MOD_RES         928
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        334
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        426
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        480
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   984 AA;  109883 MW;  521EAC240D8FB91A CRC64;
     MALDCLLLFL LASAVAAMEE TLMDTRTATA ELGWTANPAS GWEEVSGYDE NLNTIRTYQV
     CNVFEPNQNN WLLTTFINRR GAHRIYTEMR FTVRDCSSLP NVPGSCKETF NLYYYETDSV
     IATKKSAFWS EAPYLKVDTI AADESFSQVD FGGRLMKVNT EVRSFGPLTR NGFYLAFQDY
     GACMSLLSVR VFFKKCPSIV QNFAVFPETM TGAESTSLVI ARGTCIPNAE EVDVPIKLYC
     NGDGEWMVPI GRCTCKAGYE PENSVACKAC PAGTFKASQE AEGCSHCPSN SRSPSEASPI
     CTCRTGYYRA DFDPPEVACT SVPSGPRNVI SIVNETSIIL EWHPPRETGG RDDVTYNIIC
     KKCRADRRSC SRCDDNVEFV PRQLGLTECR VSISSLWAHT PYTFDIQAIN GVSSKSPFPP
     QHVSVNITTN QAAPSTVPIM HQVSATMRSI TLSWPQPEQP NGIILDYEIR YYEKEHNEFN
     SSMARSQTNT ARIDGLRPGM VYVVQVRART VAGYGKFSGK MCFQTLTDDD YKSELREQLP
     LIAGSAAAGV VFVVSLVAIS IVCSRKRAYS KEAVYSDKLQ HYSTGRGSPG MKIYIDPFTY
     EDPNEAVREF AKEIDVSFVK IEEVIGAGEF GEVYKGRLKL PGKREIYVAI KTLKAGYSEK
     QRRDFLSEAS IMGQFDHPNI IRLEGVVTKS RPVMIITEFM ENGALDSFLR QNDGQFTVIQ
     LVGMLRGIAA GMKYLSEMNY VHRDLAARNI LVNSNLVCKV SDFGLSRYLQ DDTSDPTYTS
     SLGGKIPVRW TAPEAIAYRK FTSASDVWSY GIVMWEVMSF GERPYWDMSN QDVINAIEQD
     YRLPPPMDCP AALHQLMLDC WQKDRNSRPR FAEIVNTLDK MIRNPASLKT VATITAVPSQ
     PLLDRSIPDF TAFTTVDDWL SAIKMVQYRD SFLTAGFTSL QLVTQMTSED LLRIGVTLAG
     HQKKILSSIH SMRVQMNQSP SVMA
//
